Bisphosphonate Treatment of Osteogenesis Imperfecta
| Status: | Completed |
|---|---|
| Conditions: | Orthopedic |
| Therapuetic Areas: | Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | Any - 17 |
| Updated: | 6/2/2017 |
| Start Date: | June 2003 |
| End Date: | May 2007 |
The primary purpose of this trial is to evaluate whether the investigational medication is
safe, effective and has the ability to increase spine bone density in osteogenesis
imperfecta (OI) patients.
safe, effective and has the ability to increase spine bone density in osteogenesis
imperfecta (OI) patients.
Inclusion
- Male or Female children between 3 months and 17 years old
- OI type I, III or IV
Exclusion
- Deformity or abnormality which would prevent spine bone density from being done
- Any surgical bone-lengthening procedure
- Any kidney diseases or abnormalities
- Low calcium or vitamin D levels in the blood
Other protocol-defined inclusion/exclusion criteria may apply.
We found this trial at
10
sites
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
Click here to add this to my saved trials
Alfred I. duPont Hospital for Children Nemours began more than 70 years ago with the...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials